| Medical and Health Sciences | Lifetime | 214 | US 117 | 99.99 |
| Biological Sciences | Lifetime | 405 | US 238 | 99.95 |
| Medical and Health Sciences | 2021-2025 | 125 | US 52 | 99.98 |
| Biological Sciences | 2021-2025 | 171 | US 31 | 99.84 |
| Mathematics and Statistics | 2021-2025 | 877 | US 180 | 91.70 |
| Epidemiology | Lifetime | 18 | US 11 | 99.97 |
| Infectious Diseases | Lifetime | 8 | US 4 | 99.95 |
| Cell Biology | Lifetime | 183 | US 116 | 99.07 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 356 | US 206 | 99.15 |
| Public, Environmental and Occupational Health | Lifetime | 769 | US 398 | 98.91 |
| Immunology | Lifetime | 464 | US 241 | 98.73 |
| Safety Research | Lifetime | 425 | US 244 | 97.53 |
| Microbiology | Lifetime | 344 | US 159 | 93.96 |
| Statistics, Probability and Uncertainty | Lifetime | 612 | US 232 | 93.60 |
| Endocrinology | Lifetime | 490 | US 206 | 87.87 |
| Clinical Biochemistry | Lifetime | 730 | US 314 | 83.51 |
| Parasitology | Lifetime | 683 | US 273 | 84.29 |
| Infectious Diseases | 2021-2025 | 3 | US 2 | 99.90 |
| Epidemiology | 2021-2025 | 38 | US 11 | 99.79 |
| Molecular Biology | 2021-2025 | 353 | US 97 | 98.31 |
| Plant Science | 2021-2025 | 266 | US 34 | 97.29 |
| Cell Biology | 2021-2025 | 82 | US 29 | 93.58 |
| Information Systems and Management | 2021-2025 | 220 | US 49 | 84.19 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 741 | US 255 | 82.67 |
| Immunology | 2021-2025 | 770 | US 276 | 74.52 |
| Statistics, Probability and Uncertainty | 2021-2025 | 282 | US 54 | 73.43 |
| Ecology, Evolution, Behavior and Systematics | 2021-2025 | 554 | US 130 | 64.85 |
| Nail Diseases and Treatments | Lifetime | 1 | US 1 | 99.95 |
| Fungal Infections and Studies | Lifetime | 2 | US 2 | 99.97 |
| COVID-19 Clinical Research Studies | Lifetime | 9 | US 3 | 99.91 |
| Antifungal resistance and susceptibility | Lifetime | 4 | US 3 | 99.96 |
| Bacillus and Francisella bacterial research | Lifetime | 3 | US 3 | 99.80 |
| Plant Pathogens and Fungal Diseases | Lifetime | 14 | US 5 | 99.88 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 13 | US 3 | 99.89 |
| Toxin Mechanisms and Immunotoxins | Lifetime | 5 | US 4 | 99.76 |
| Cytomegalovirus and herpesvirus research | Lifetime | 30 | US 20 | 99.66 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 104 | US 69 | 99.74 |
| Zoonotic diseases and public health | Lifetime | 19 | US 9 | 99.45 |
| Health and Medical Research Impacts | Lifetime | 22 | US 12 | 98.88 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 28 | US 12 | 99.27 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 110 | US 50 | 99.34 |
| Long-Term Effects of COVID-19 | Lifetime | 181 | US 49 | 98.25 |
| Yeasts and Rust Fungi Studies | Lifetime | 51 | US 18 | 99.00 |
| melanin and skin pigmentation | Lifetime | 83 | US 38 | 98.75 |
| Infectious Diseases and Mycology | Lifetime | 67 | US 30 | 98.87 |
| Bacteriophages and microbial interactions | Lifetime | 294 | US 169 | 98.92 |
| COVID-19 Impact on Reproduction | Lifetime | 58 | US 27 | 98.12 |
| Academic integrity and plagiarism | Lifetime | 9 | US 6 | 98.51 |
| Plant-Microbe Interactions and Immunity | Lifetime | 257 | US 70 | 98.93 |
| Mycobacterium research and diagnosis | Lifetime | 353 | US 130 | 98.13 |
| Galectins and Cancer Biology | Lifetime | 198 | US 78 | 97.70 |
| Viral Infections and Outbreaks Research | Lifetime | 177 | US 91 | 98.21 |
| Bacterial Infections and Vaccines | Lifetime | 238 | US 97 | 97.96 |
| Tuberculosis Research and Epidemiology | Lifetime | 677 | US 213 | 97.69 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 154 | US 65 | 95.86 |
| SARS-CoV-2 detection and testing | Lifetime | 265 | US 69 | 95.43 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 749 | US 299 | 96.68 |
| vaccines and immunoinformatics approaches | Lifetime | 275 | US 137 | 96.83 |
| Parasitic Infections and Diagnostics | Lifetime | 413 | US 153 | 96.79 |
| Phytoplasmas and Hemiptera pathogens | Lifetime | 162 | US 75 | 95.93 |
| Streptococcal Infections and Treatments | Lifetime | 741 | US 319 | 96.39 |
| Plant Disease Resistance and Genetics | Lifetime | 809 | US 277 | 96.22 |
| Biomedical and Engineering Education | Lifetime | 303 | US 185 | 92.12 |
| scientometrics and bibliometrics research | Lifetime | 220 | US 65 | 94.17 |
| Studies on Chitinases and Chitosanases | Lifetime | 240 | US 45 | 92.85 |
| bioluminescence and chemiluminescence research | Lifetime | 557 | US 245 | 92.53 |
| Academic Publishing and Open Access | Lifetime | 60 | US 19 | 92.21 |
| Legionella and Acanthamoeba research | Lifetime | 471 | US 166 | 89.31 |
| Science, Research, and Medicine | Lifetime | 318 | US 161 | 82.70 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 7 | US 5 | 99.89 |
| COVID-19 Clinical Research Studies | 2021-2025 | 8 | US 2 | 99.89 |
| Fungal Infections and Studies | 2021-2025 | 2 | US 1 | 99.86 |
| Antifungal resistance and susceptibility | 2021-2025 | 8 | US 2 | 99.63 |
| vaccines and immunoinformatics approaches | 2021-2025 | 15 | US 5 | 98.79 |
| COVID-19 Impact on Reproduction | 2021-2025 | 28 | US 10 | 98.03 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 161 | US 60 | 96.16 |
| SARS-CoV-2 detection and testing | 2021-2025 | 146 | US 35 | 96.30 |
| Plant Pathogens and Fungal Diseases | 2021-2025 | 177 | US 22 | 97.07 |
| Long-Term Effects of COVID-19 | 2021-2025 | 489 | US 113 | 95.60 |
| Nail Diseases and Treatments | 2021-2025 | 47 | US 14 | 96.52 |
| Viral Infections and Outbreaks Research | 2021-2025 | 101 | US 31 | 94.43 |
| Bacillus and Francisella bacterial research | 2021-2025 | 58 | US 15 | 93.12 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 415 | US 142 | 93.78 |
| Zoonotic diseases and public health | 2021-2025 | 125 | US 29 | 92.50 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 597 | US 202 | 93.05 |
| Cytomegalovirus and herpesvirus research | 2021-2025 | 375 | US 144 | 86.71 |
| Fungal Biology and Applications | 2021-2025 | 509 | US 22 | 87.09 |
| Blood groups and transfusion | 2021-2025 | 814 | US 220 | 75.32 |
| scientometrics and bibliometrics research | 2021-2025 | 404 | US 55 | 67.44 |
| Academic integrity and plagiarism | 2021-2025 | 169 | US 30 | 60.85 |
| Phytoplasmas and Hemiptera pathogens | 2021-2025 | 734 | US 173 | 58.71 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 942 | US 130 | 55.65 |
| Academic Publishing and Open Access | 2021-2025 | 175 | US 27 | 55.47 |